MetaCap

First Tracks Biotherapeutics Inc. Company Profile

NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.64-2.82 (-6.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

First Tracks Biotherapeutics at a glance

First Tracks Biotherapeutics Inc. (NASDAQ: TRAX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA. First Tracks Biotherapeutics is led by Mr. Daniel R. Faga and employs about 104 people. At a market capitalization of $1.75 billion, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0002091349, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does First Tracks Biotherapeutics do?

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
First Tracks Biotherapeutics Inc.
Ticker
NASDAQ: TRAX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Daniel R. Faga
Employees
104
Headquarters
10770 Wateridge Circle, San Diego, CA, United States
Phone
858 362 6295
SEC CIK
0002091349

Companies similar to First Tracks Biotherapeutics

TRAX peer companies
CompanyPrice% ChgMarket capCompare
STOKStoke Therapeutics Inc.26.81-0.45%$1.75Bvs TRAX
ETONEton Pharmaceuticals Inc.60.85-0.83%$1.76Bvs TRAX
SDGRSchrodinger Inc.22.93-12.95%$1.72Bvs TRAX
KRSAKorsana Biosciences Inc.37.56+5.95%$1.71Bvs TRAX
ZYMEZymeworks Inc.26.14-2.68%$1.81Bvs TRAX
MRVIMaravai LifeSciences Holdings Inc. Class A6.98-2.92%$1.81Bvs TRAX
RAREUltragenyx Pharmaceutical Inc.16.48-4.30%$1.68Bvs TRAX
BRVEBraveheart Bio Inc.20.39+5.81%$1.67Bvs TRAX

Related